FOLFOX4 Plus Cetuximab for Patients With Previously Untreated Metastatic Colorectal Cancer According to Tumor RAS and BRAF Mutation Status: Updated Analysis of the CECOG/CORE 1.2.002 Study
Keywords: BRAF mutation; Cetuximab; FOLFOX4; Metastatic colorectal cancer; RAS mutation;